Program News
News and stories about the UNC Lineberger Lymphoma Program
-
Experience sparks patient’s passion for helping others
Janine Jones has one mission in her life – to be a voice for fellow cancer patients, helping others navigate their cancer journeys.
-
Studies find combination chemotherapy beneficial and cost-effective in sub-Saharan Africa
Matthew Painschab, MD, and colleagues report that a five-drug combination chemotherapy provided curative benefit in people diagnosed with diffuse large B-cell lymphoma and is also a cost-effective option in Malawi.
-
NCI grant funds UNC-led consortium studying HIV-related cancers in sub-Saharan Africa
A team of UNC researchers are partnering with colleagues at three institutions in Africa to study HIV-associated malignancies: Kaposi sarcoma, cervical cancer and lymphoma.
-
Dittus and colleagues write the book on rare lymphomas
UNC Lineberger’s Christopher Dittus, DO, MPH, assistant professor of medicine at UNC School of Medicine, is the editor of a new book that provides a comprehensive review of how to diagnose and manage rare lymphomas, with a focus on novel treatment approaches. UNC Lineberger faculty and trainees contributed chapters to the volume. “Novel Therapeutics for … Read more
-
Leukemia & Lymphoma Society grant supports drug discovery research
The Leukemia & Lymphoma Society has awarded a $971,484 Screen to Lead grant to University of North Carolina Lineberger Comprehensive Cancer Center researchers to launch an investigation of new drug compounds that would block enzymes that can become hyperactive in blood cancer cells when mutated. UNC Lineberger’s John Sondek, PhD, a professor in the UNC … Read more
-
Former patient donates $10 million to further blood cancer research at UNC Lineberger
Etteinne “ET” and W. G. Champion “Champ” Mitchell of New Bern, North Carolina, will create a new fund supporting ground-breaking research in blood cancer at UNC Lineberger Comprehensive Cancer Center, including lymphoma, leukemia and myeloma research, in gratitude for the care Champ received and to bolster research directed at finding cures.